Clinical trials
Completed Phase 2 Candidiasis, Vulvovaginal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scynexis, Inc. | 2 |
| Viamet | 2 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Ferrer Internacional S.A. | 1 |
| Matinas BioPharma Nanotechnologies, Inc. | 1 |
| MethylGene Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Toltec Pharmaceuticals, LLC | 1 |
| University of Roma La Sapienza | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Candidiasis, Vulvovaginal | 11 |
| Candidiasis | 3 |
| Vaginitis | 2 |
| Vaginosis, Bacterial | 2 |
| Atypical Squamous Cells of the Cervix | 1 |
| Mycoses | 1 |
| Papillomavirus Infections | 1 |
| Trichomonas Infections | 1 |
| Vaginal Diseases | 1 |
| Vulvovaginitis | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.